Medical Distribution Industry | Healthcare Sector | Mr. Pao-Chi Chu CEO | OTCQB Exchange | US0048921052 ISIN |
United States Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Acro Biomedical Co., Ltd. is a company that operates in the health and wellness sector, focusing on the development and marketing of nutritional products. Originally established under the name Killer Waves Hawaii, Inc., the company underwent a rebranding in January 2017, adopting its current identity. Since its incorporation in 2014, Acro Biomedical has positioned itself in the market by leveraging the traditional Chinese medicine heritage of its key product offerings. With its headquarters located in Fishers, Indiana, the company has successfully bridged Eastern medicinal traditions with Western health culture, aiming to carve a unique niche for itself within the competitive nutritional products landscape.
At the heart of Acro Biomedical’s product line is cordyceps, a highly valued fungus in traditional Chinese medicine known for its potential health benefits. The company has focused its research and development efforts on harnessing the medicinal properties of cordyceps, aiming to offer products that support overall health, vitality, and wellness. Cordyceps-based products are marketed as nutritional supplements, appealing to consumers seeking natural remedies and supplements to enhance their health regimen.